[ARWR] YoY Quarter Result on 31-Dec-2023 [#Q1]

Stock
[ARWR] Arrowhead Pharmaceuticals, Inc.
Announcement Date
06-Feb-2024
Financial Year
2024
Quarter
31-Dec-2023 [#Q1]
Profit Trend
QoQ- -21.14%
YoY- -217.77%
Quarter Report
ARWR's Result
ARWR's Financial Summary
View:
Show?
Quarter Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 3,551 62,546 27,439 21,303 29,455 34,658 3,510 0.19%
PBT -138,689 -41,794 -62,872 -20,732 -2,674 12,037 -13,199 47.96%
Tax -3,313 17 -1,156 -2,169 1 -0 -614 32.41%
NP -132,864 -41,811 -62,872 -20,732 -2,674 12,037 -13,199 46.91%
Tax Rate - - - - - 0.00% - -
Total Cost 136,415 104,357 90,311 42,035 32,128 22,621 16,709 41.87%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin -3,741.59 -66.85 -229.13 -97.32 -9.08 34.73 -376.06 46.63%
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
EPS -1.24 -0.39 -0.60 -0.20 -0.03 0.13 -0.18 37.92%
EPS Diluted -1.24 -0.39 -0.60 -0.20 -0.03 0.13 -0.18 37.92%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.